Anfeng Luo
Research Field
Biography
Dr. Anfeng Luo obtained his M.D./Ph.D. degree from the Department of Immunology at Capital Medical University’s School of Basic Medical Sciences. He subsequently joined Yale University School of Medicine as a postdoctoral researcher. His research focuses on cancer drug resistance and the molecular mechanisms regulating neural stem cell proliferation and differentiation, with a specialization in biochemical and epigenetic techniques.
Dr. Luo has received numerous awards, including the National Graduate Student Scholarship and the Capital Medical Academic Rising Star Award. Additionally, he has participated in several research projects funded by the Beijing Municipal Science and Technology Commission and the National Natural Science Foundation of China.
As both the first and co-first author, Dr. Luo has published a series of peer-reviewed SCI papers in prestigious journals such as Nature Communications, Stem Cell Reports, and Molecular Cell. Notably, his article in Nature Communications was featured as an editor's highlight, and his publication in Molecular Cell appeared in the form of a preview.
Enter your email to receive alerts when new articles and issues are published.
Brain Conflux is open access. All content is freely available to read, download and share immediately upon publication.
Brain Conflux is licensed under a Creative Commons Attribution 4.0 International License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Submission of a manuscript to the Brain Conflux journal directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet.
The content provided by the authors in the manuscript should at no point of time breach the Copyrights or rights of a third party. The manuscript submitted should not be published or submitted for consideration in any other journal. Manuscripts with plagiarized content will not be considered for the peer-review process.
DOI is registered through Crossref to ensure that each content has a unique identifier and supports citation statistics and long-term content preservation.